Page 8 - MSM Campaign Council Webinar - June 2021
P. 8

ADVANCING HEALTH EQUITY | PHARMACEUTICAL PARTNERSHIPS







               James W. Lillard, Jr., PhD, MBA                                                                          Dr. Lillard joined MSM’s faculty as Professor of Microbiology,

               Entrepreneur in Residence | National Academy of Inventors Fellow                                         Biochemistry & Immunology and Assistant Dean for Research. In July
               American Association for the Advancement of Science Fellow                                               2011, Dr. Lillard  established the Office of Translational Technologies at
               44 h-index | 75 i10-index                                                                                MSM, where he serves as its Director. Since 2018, he  has served as the
                                                                                                                        Program Director of the online MS in  Biotechnology program at MSM,
               AcademicAppointments                                                                                     which is now ranked  #1 out of 139 similar programs by Intelligent.com. He  is
               Associate Dean for Research Affairs, Morehouse School ofMedicine                                         the Program Director of the online MS in Health  Informatics program. Dr.
               PI, AACR President’s 2020 by 2020 Initiative & Total Cancer Care Protocol                                Lillard serves as the Director  of the Georgia Research Alliance Ventures
               MPI, NCI U54 MSM/TU/UAB CCC Partnership                                                                  Program  and Associate Dean for Research Affairs at Morehouse  School of
               Director, OTT & GRA Ventures at Morehouse School of Medicine                                             Medicine. He has helped establish biotechcompanies and contributed to
               Director, online MS Biotechnology and MS Health Informatics Programs                                     the formation and commercialization plans of others, as scientific and
               Professor, Microbiology, Biochemistry & Immunology                                                       business advisor and/or founder.
               IndustryAppointments                                                               ResearchInterests
               President & CEO, JYANT Technologies, Inc.                                          Dr. Lillard is an immuno-biologist who uses both in silico and in vivo methods  to develop biologics and
               Scientific Advisor, WellesleyPharmaceuticals, Inc.
               Board of Advisors – Member, DevMar Manufacturing, Inc.                             other technologies to diagnose, prevent, and/or treat  cancer and infectious diseases.
               Scientific Medical Advisory Board – Ciitizen Corporation
                                                                                                  Most recently, his laboratory research involves  dissecting G protein-coupled receptors effects on cancers
               James Lillard completed his B.S. degree in Electrical Engineering & Computer  Science from the   progression and  immunity. James is the principal investigator of the Total Cancer Care protocol,  which
               Ohio State University and worked as a product development  engineer for IBM. He received his Ph.D.   aggregates and analyzes clinically annotated WGS/WES/WTS data from  African American cancer
               in Microbiology & Immunology from  the University of Kentucky School of Medicine, where he   patients/survivors to generate medical reports and  identify new drug targets and diagnostic markers,
               studied Yersinia “plague” pathogenesis. Dr. Lillard completed post-doctoral training in mucosal    making it the largest initiative of its kind. His research contributions span multiple disciplines including
               immunology at the University of Alabama at Birmingham. He has worked as an  Assistant, Associate,   oncology, vaccine development, and biodefense.
               and now Full Professor in the Department of Microbiology,Biochemistry, and Immunology at
               Morehouse School of Medicine, University  of Louisville School of Medicine, and completed an   Dr. Lillard’s cumulative peer-reviewed funding principally directed over his scientific career exceeds $55
               Executive MBA from the  Goizueta BusinessSchoolatEmoryUniversitywithafocuson       million  and he has authored over 300 scientific communications, which have been cited  over 8,400
               Biotechnology.                                                                     times. Dr. Lillard’s articles have appeared in International Journal of  Cancer Research, Clinical Cancer
                                                                                                  Research, Journal of Clinical Investigations, Journal Immunology, Laboratory Investigations, and
               LeadershipRoles                                                                    Proceedings of the National Academy of Sciences USA. His work is well-recognized as indicated by his
               Dr. Lillard was the Smith & Lucille Gibson Endowed Chair in Medicine, Senior Scientist at the   appointment as a NAI Fellow, AAAS Fellow, and service on editorial boards and  scientific review for the
               James Graham Brown Cancer Center, and Vice Chair for  Research & Professor in the   NIH, VA, DoD, US FDA, industry advisory panels and  studysections.
               Department of Microbiology & Immunology at  the University of Louisville.
                                                                                                                                                     msmimpact.org
   3   4   5   6   7   8   9   10   11   12   13